AllDocs -> cancers

Introduction Brain metastases are common patterns of dis- semination in lung cancer patients. In the natural course of disease in around 17% of pa- tients with squamous carcinoma, in 24% of patients with anaplastic carcinoma, in 39% of patients with adenocarcinoma and in 42% with small cell carcinoma brain metastases will develop. 1 Admittedly non-small cell car- Radiol Oncol 2003; 37(4): 213-6. Brain metastases in lung cancer . Impact of prognostic factors on patient survival Uroš Smrdel, Matjaž Zwitter, Viljem Kovac Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia Background. Brain metastases are common patterns of dissemination in lung cancer patients. In this paper we would like to assess the pattern of brain metastases in lung cancer patients and the impact of prognos- tic factors ...

Introduction Lung malignancies represent a repeated problem in the respiratory clinics constantly arousing attention due to the rapid evolution, extremely bad prognosis and frightening number of new patients every following year. Lung cancer is the most frequent pathology among all malignancies with more than 1000 000/year, and the main cause of death in 29% in this pathology. The distribution shows dominance in the developing countries with 61%, mainly due to the early presence of smoking habits. 1,2 The 5-year survival is the lowest one, compared to the most frequent cancers: (colon 63%, breast 83%, prostate can- cer 93%). 2,3 It remains alarmatic low: from 8% in 1960 to 14% 2001. On the other hand there is a dramatic difference in the 5-year survival, related to the stadium of the disease. The lo- calized form of the disease shows ...

Introduction Lung cancer is a severe disease often diag- nosed a late stage when surgical resection is no longer possible because of local advance- ment or distant metastasis. 1 Bone metastases from lung cancer may occur early in the clin- ical course and are usually discovered with severe pain. 2-4 The spine and ribs are often the earliest sites of bone metastases, whereas the skull, femur, humerus, and scapula are involved lat- er. 5 Pubic bone metastasis as the initial man- ifestation of lung cancer is very rare. We re- port a case of particular interest because of unusual bone metastatic site and the relative- ly slow progression of the neoplasm. Case report A 65-year-old woman was referred to her or- thopedist with pain in the right flank, which extended to the anterior aspect of the thigh for ...

Heine H Hansen is Professor at the Finsen Center, the National University Hospital, Denmark. He has also been Professor (Personal Chair) of Clinical Oncology at the University of Copenhagen since 1991. He is a Past Chairman of the Danish Society for Cancer Research and the Danish Society for Medical Oncology; a Past President of the International Association for the Study of Lung Cancer (IASLC) and the European Society of Medical Oncology (ESMO); and a Past Executive Director of the IASLC. Professor Hansen has published more than 300 articles in international journals on basal and clinical aspects of cancer , with special emphasis on lung cancer and other solid tumours, and on the development of new anticancer agents. In addition, he is the editor of several Danish and international textbooks and, since 1985, has been Editor-in-Chief ...

providing research and information services to the Scottish Parliament 1 Research Note 00/95 13 November 2000 LUNG CANCER AND ASBESTOS (MESOTHELIOMA) This note provides background information on S1M-1273, for debate on 16 November 2000, on compensation for mesothelioma sufferers. THE ISSUE S1M-1273 reads: 'that the Parliament notes the plight of shipyard workers and their families who were exposed to asbestos, became ill and have now contracted mesothelioma; expresses concern over the length of time their compensation cases are taking to reach conclusion and the use of so-called "blanket denials" by the defenders, and notes that this practice victimises and denies justice to these cancer sufferers.' 1 Sufferers have in mind to persuade the Parliament to precipitate a change in the law that will allow compensation claims to proceed more quickly ...

Ÿ Neuroanatomy, 2002, Volume1, Pages 26-28. Case Report Non-small cell lung cancer presenting as a bilateral metastatic brachial plexopathy Necdet Karli (1) Kader Karli Oguz (2) Mehmet Zarifoglu (1) Nebahat Bilici (1) Ozgur Cakir (3) (1) Department of Neurology, University of Uludag, School of Medicine, Gorukle, Bursa, Turkey. (2) Department of Radiology, Hacettepe University, School of Medicine, Sihhiye, Ankara, Turkey. (3) Department of Radiology, University of Uludag, School of Medicine, Gorukle, Bursa, Turkey Correspondence Address Kader Karli Oguz, MD. Hacettepe University, School of Medicine Dept of Radiology 06100 Sihhiye Ankara Turkey Telephone: +90-312 3051188 Fax: +90-312 3112145 E-mail: karlioguz@yahoo.com Received 2 December 2002; accepted 13 December 2002 Abstract Squamous cell carcinoma may ...

East Shore Hospital, Gleneagles Hospital, Mount Elizabeth Hospital Jan-Mar 2004 http://www.pgh.com.sg L I N K MITA (P) NO. 121/03/2003 Call our 24-hour Medical Referral Centre (MRC) : (65) 6735 5000 (Local toll free) | Email: mrc@parkway.com.sg | Website: http://www.imrc.com.sg New Low Dose CT Screens for Lung Cancer - The Silent Killer According to the World Health Organisation, lung cancer is responsible for the most deaths among men in Southeast Asia. In Singapore, it is the most common cancer in males and the third most frequent cancer in females (source: Singapore Cancer Registry, Report No. 4). LUNG CANCER develops when toxic substances, usually found in tobacco smoke, damage cells in the lung . The cancer can start in various parts ...

Comparison of States With Highest Rates of Lung Cancer , Their Tobacco Settlement Revenues & Expenditures States With Highest Rates of Lung Cancer Among MEN Tobacco-Control Programs Lung Cancer Rates Among Men* Revenue Per Capita** Expenditures Per Capita** CDC Recommended Amount** 1. Kentucky 121.7 $25.98 $0.84 $6.42 2. West Virginia 104.4 30.41 4.31 7.80 3. Louisiana 101. 3 31.33 0.37 6.23 4. Missouri 95.6 25.40 0.43 6.07 5. Delaware 95.4 29.99 4.61 11.80 6. North Carolina 93.9 17.73 0.32 5.74 7. Rhode Island 91.4 42.54 3.03 10.01 ...

Listing of Lung Cancer Rates and Spending on Tobacco Control Programs State Lung Cancer Rates Among Men* Lung Cancer Rates Among Women* CDC Lung Cancer Rates Among Men** CDC Lung Cancer Rates Among Women** Expenditures Per Capita*** CDC Recommended Amount** Revenue Per Capita*** Total Revenue Amount*** Alabama 84.5 35.8 n/a n/a $0.30 $6.19 $21.81 $97,000,000.00 Alaska 74.9 52.6 43 42.5 $4.01 $13.27 $33.82 $21,200,000.00 Arizona 66.8 41.8 69.5 52 $7.32 $6.10 $17.09 $87,700,000.00 Arkansas n/a n/a n/a n/a $0.58 $7.10 $19.23 $51,400,000.00 California 65.8 43 54.3 ...

106 Mountain © 2000 Wiley-Liss, Inc. Seminars in Surgical Oncology 2000; 18:106–115 SSU 934 The International System for Staging Lung Cancer CLIFTON F. MOUNTAIN, MD* Division of Cardiothoracic Surgery, The University of California at San Diego, San Diego, California The International System for Staging Lung Cancer is a consistent, reproducible classification for the anatomic extent of disease in patients with lung cancer . A revision of the system in use since 1986 included modifications of the rules for stage grouping the TNM (T-primary tu- mor, N-regional lymph nodes, and M-distant metastasis) anatomic subsets. More specific stage categories and consistency for reporting the end results for Stage I, Stage II, and Stage IIIA disease are provided. Survival data support the revised categories and confirm the sig- nificant relationship between ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com Lung Cancer and Exposure to Ionizing Radiation 1 Lung Cancer and Exposure to Ionizing Radiation Summary : Studies conducted at the Los Alamos National Laboratory and other nuclear facilities suggest an increased likelihood of developing lung cancer for workers who have been exposed to ionizing radiation. These findings are consistent with the determination of the National Research Council’s BEIR V committee that lung tissue if sensitive to ionizing radiation. Lung cancer is a “specified” cancer under the Energy Employees Occupational Illness Compensation Program Act. Historically, lung cancer incidence and mortality ranked among the lowest in the state for both Los Alamos and Rio Arriba Counties. Incidence ...

NMT BRIEFS New Medical Therapies Lung Cancer L ung cancer is the leading cause of cancer deaths worldwide, with an estimated 171,900 new cases of lung cancer and an estimated 157,200 deaths from lung cancer in the U.S. in 2003. Although incidence appears to be decreasing among white and African- American men in the U.S., it continues to rise among both white and African-American women. Each year, lung cancer kills more men than does prostate cancer and more women than does breast cancer . Non-small cell lung cancer (NSCLC), which includes squamous cell carcinoma, adenocarci- noma, and large cell carcinoma, is the most prevalent form of lung cancer . Small cell lung cancer (SCLC), or oat cell cancer , accounts for about 20% of all cases of lung cancer ...

lung cancer November is ? lung cancer awareness month A group of lung cancer nurses from the Yorkshire region are trying to raise awareness of the dangers of the disease throughout the month of November. The forum, which is made up of Macmillan and hospital trust nurses, will be on hand with leaflets and displays within the local hospitals and health centres across the district, trying to get across the message ?early diagnosis saves lives?. Janet Harrison, Lung Cancer Nurse Specialist at Airedale NHS Trust: ?Here at Airedale we have an excellent level of care of lung cancer patients and we have a very personal service. Our team of staff has recently been shortlisted for a national award because of the level and type of care we provide. We try and keep the patient as number one and follow a holistic approach. ? Everyone is at risk, but if you smoke or ...

1 The Centers for Disease Control and Prevention (CDC) recently examined trends in mortality rates for the four leading sites for cancer -related deaths: lung /bronchus, colon/ rectum, prostate, and breast. These four sites are associated with 53% of all cancer -related deaths in the United States. Using the National Vital Statistics System, the CDC calculated the trends in mortality rates among whites, blacks, American Indians and Alaska Natives (AI/AN), Asians and Pacific Islands (API), and Hispanics. They found that AI/AN rates for lung , colorectal, and breast cancers have increased. These same rates, with the exception of lung cancer in women, have decreased over the other racial/ ethnic groups. Lung and bronchus cancer was responsible for over a quarter of all cancer deaths ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:r3Nflxl5Vh8J:www.cdphe.state.co.us/pp/ccpc/fslungcancer.pdf allintitle: lung cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Lung Cancer Guidelines Review 20/12/2001 Rosemary Tate 1 of 4 Lung Cancer Guidelines Review for Radical Therapy in Non-Small Cell Lung Cancer Project 20/12/2001 Rosemary Tate Collating Scottish Intercollegiate Guidelines Network SIGN (1998), with British Thoracic Society BTS (1998 and 2001) and Royal College of Radiologists RCR (1999) Guidelines and whether BTS Lung Cancer Core Data Set CDS (1999) and RCR Lung Cancer Core Data Set COIN (1999) are appropriate The following recommendations have been selected from the BTS (1998 and 2001), the RCR (1999), and the SIGN (1998) guidelines. The BTS (1998) recommendations principally concern the process of patient care, most of them represent considered clinical opinion compatible with what evidence there is and are not recommendations based upon published scientific evidence. They tend to concentrate on ...

The Japan Lung Cancer Society Emuzu Bldg. 401, 9-8 Chuo 4-chome, Chuo-ku, Chiba, 260-0013, Japan President: Koichi Kobayashi Former Presidents: Yoshikazu Kawakami (1999), You Watanabe (1998), Shigefumi Fujimura (1997), Michio Kono (1996) English Edition Subcommittee Members: Subcommittee Chairman: Harubumi Kato Norihiko Kawate, Koichi Kobayashi, Michio Kono, Chimori Konaka, Tsuguo Naruke, Sumio Nitta, Hidemi Ohwada, Nagahiro Saijo Adviser: Masanobu Kitagawa English Language Consultant: J. Patrick Barron

Lun gC anc er Prevention & Early Detection Save Lives. The Power Is Yours. Prevention & Early Detection Save Lives. The Power Is Yours. LUNG CANCER EVALUATION & TREATMENT Page 2 The Lung Cancer Evaluation & Treatment Center. Hope Prevention Recovery Lung cancer . It’s one of the most common cancers in both men and women – more deadly than breast, prostate and colon cancers combined. Is it any wonder such a daunting fact fills many people with fear and hopelessness? But at Cancer Treatment Centers of America, we don’t believe in fear. We believe in fighting. Not long ago, people with early stage lung cancer had no way of knowing they had the disease. Screening and treatment techniques simply were not ...

Brochure More information from http://www.researchandmarkets.com/reports/39147 Lung Cancer : Novel Therapeutics with Potential to Drive Market Success Description: Lung cancer is the second most commonly occurring non-cutaneous cancer and the leading cause of cancer deaths in the United States. Worldwide the incidence rates vary however, lung cancer remains a leading cause of cancer mortality-reported by the World Health Organization to have caused 1.1 million deaths in 1997. Current treatments are, for the most part, ineffective the five-year survival rate for lung cancer patients has remained unchanged at 14% for the last twenty years. Lung cancer is a disease with a dismal prognosis. Patients usually have advanced disease at diagnosis. New therapeutic options range from modifications of conventional drugs that improve their pharmacokinetic ...

lung cancer Patient Reported Outcomes as Endpoints in Lung Cancer and Thoracic Malignancies Richard J. Gralla, MD New York Lung Cancer Alliance For the ASCO and FDA Working Group PATIENT REPORTED OUTCOMES (“PROs”) - Clinical Benefit and Quality of Life - Quality of Life Multidimensional Includes areas not likely to be affected by chemo Clinical Benefit Subjective or Palliative Control of Common Problems Previously Defined to Include such considerations as: Pain Control Weight Loss Performance Status QUALITY OF LIFE AND PRO EVALUATION - Is there a Need in Studies of Anticancer Treatments? - Highly Symptomatic Disease Survival and Response ...

B e t t e r H e a l t h f o r W o m e n : A G l o b a l H e a l t h P r o g r a m B r i s t o l - M y e r s S q u i b b F o u n d a t i o n , I n c . L U N G C A N C E R I N W O M E N z2370 6/4/02 3:22 PM Page 1 Page 2 I n 1998, more than 70,000 women died of lung cancer in the U.S. That’s more than the number of women who died as a result of breast and ovarian cancers combined. The sad fact is that the disease – the number one cancer killer in the U.S. – is on the rise in women: according to the American Cancer Society, in the 20-year span between 1974 and 1994, lung cancer deaths among women increased by 147 percent; by contrast, the number of deaths among men increased 20 percent over that same time period. In 1998 alone, more than 80,000 new cases of female lung cancer were diagnosed. And the prognosis ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:j44DS90XRTcJ:www.researchandmarkets.com/reports/835/835.pdf allintitle: lung cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Brochure More information from http://www.researchandmarkets.com/reports/932 Treatment Algorithms 2001: Lung Cancer Description: Utilizing primary data amassed from in-depth interviews with primary care physicians and cancer specialists across the seven major markets of the US, Japan, France, Germany, Italy, Spain and the UK, this report provides a detailed analysis of the diagnosis and treatment of lung cancer . A comparison is presented of current medical practice in lung cancer treatment, alongside key global conclusions and input from opinion leading lung cancer specialists. Contents: Executive Summary Scope Datamonitor insight into the lung cancer market In Europe, and particularly in the UK, under-referral is a common and important factor limiting the patient potential of lung cancer pharmacotherapeutics. Companies must ...

Aspirin use and lung cancer in men CN Holick* ,1,2 , DS Michaud 3 , MF Leitzmann 3 , WC Willett 1,2,4,5 and E Giovannucci 1,2,4,5 1 Department of Nutrition, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA; 2 Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA; 3 Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA; 4 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA; 5 Harvard Medical School, Boston, MA 02115, USA We examined prospectively the relation between regular aspirin use and lung cancer risk in the Health Professionals Follow-Up Study. ...

LUNG CANCER RELATED JOURNALS European Journal of Cancer The Lancet Oncology Radiotherapy and Oncology International Journal of Radiatioin Oncology Biology Physics Journal of the International Association for the Study of Lung Cancer AIMS & SCOPE Lung Cancer aims to provide the members of the International Association for the Study of Lung Cancer (IASLC) and other individuals or organisations with the most recent information on lung cancer . Each issue also functions as a forum for rapid exchange of information among members of the IASLC. Lung Cancer contains up-to-date news from the IASLC, reports from national and international groups working with lung cancer , book reviews and review articles, in which selected topics on lung cancer are discussed. In addition, each issue includes a reference section derived from the Excerpta ...

Lung Cancer and Mesothelioma During Prospective Surveillance of 1249 Asbestos Insulation Workers, 1963-1974* Irving J. Selikoff Environmental Sciences Laboratory Mount Sinai School of Medicine The City University of New York New York, New York 10029 INTRODUCTION In 1963, it was found that a large group of asbestos insulation workers in the New York metropolitan area had experienced unusual mortality during 1943-1962. 1 Six hundred and thirty-two men had been on the union's rolls on January 1, 1943. By December 31, 1962, 262 men had died, nine before reaching 20 years on the job. Of those who died after 20 years from first employment, lung cancer was found in marked excess; 6.02 such deaths had been expected, and 42 occurred. In addition, there were several deaths due to pleural or peritoneal mesothelioma and a modest increase in deaths due to, gastrointestinal ...

Mortality from Lung cancer in FINLAND, 1952-95 (annual rates per 100 000) Year Male 35-54 Female 35-54 Male 55-74 Female 55-74 1952-3 41.2 3.8 251.8 23.4 1954-5 38.5 4.3 265.6 21.2 1956-7 43.3 3.1 278.7 18.6 1958-9 44.4 3.3 337.8 21.7 1960-1 47.9 3 331.6 16.6 1962-3 45.5 3.9 361.1 19.6 1964-5 46.2 3.2 366.3 18.9 1966-7 41.2 3.9 371.6 20.5 1968-9 44.9 3.6 403.8 19.1 1970-1 41.6 3.8 419.6 18.3 1972-3 38 3.4 398.1 21.7 1974-5 33.7 3.4 392.4 20.8 1976-7 37.3 4.5 410.2 26.4 1978-9 34.7 5 402.2 26.6 1980-1 32.8 4.1 383.5 31.5 1982-3 23.6 3.7 368.5 30.3 ...

Bounding analysis applied to lung cancer risk Minh Ha-Duong * Elizabeth Casman M. Granger Morgan February 7, 2003 Abstract For cancers with more than one risk factor, the sum of estimated numbers of cancers attributed to the individual factors may exceed the total number of cases observed. In this study we bound the fraction of lung cancer occurrences not at- tributed to specific well-studied causes, in order to keep estimates of the less well delimited risks consistent with those of known risks. Available data and expert judgment are used to attribute portions of the observed lung cancer incidence to known causes such as smoking, residential radon and asbestos exposure, to de- scribe the uncertainty surrounding these estimates, and quantify the interaction between pollutants. An upper bound on the residual risk is inferred using a co- herence constraint ...

lung cancer ASCO/FDA Lung Cancer Endpoints Workshop April 15, 2003 [The following comments reflect the opinions of the workshop participants and do not necessarily represent the views of the FDA] Introductory Remarks Dr. Paul Bunn welcomed everyone in attendance and noted that the ASCO/FDA Lung Cancer Endpoints Panel had intentionally been established with a broad membership?including representatives from industry, advocacy groups, and the National Cancer Institute (NCI), as well as FDA and ASCO?in order to obtain input from a wide variety of perspectives on the topic of endpoints in clinical trials whose purpose is to support applications for the approval of new anti- cancer drugs or supplemental indications for already-approved anti- cancer drugs. All panel members share an interest in getting safe and effective drugs for cancer treatment to the public as quickly as possible, he said. ...

Lung cancer is the second most common cancer , ac- counting for about one out of five malignancies in men and one out of nine in women. Unfortunately, over the past several years, while the incidence of lung cancer has gradu- ally declined in men, it has been rising alarmingly in women. In 1940 only seven women in 100,000 devel- oped the disease; today the rate is 42 in 100,000. Abstracting, Coding, & Staging Lung Cancer SEER Training Website: http://training.seer. cancer .gov/ ss_module03_lung/unit03_sec01_icdo_codes.html W HAT ’ S N EW : The 2003 Data Acquisition Manuals were mailed to all Hospitals and reporting Freestanding facilities on November 4, 2003. Please use the 2003 Data ...